GSK2795039 是一种 NADPH 氧化酶 2 抑制剂，可抑制活性氧产生和 NADPH 消耗，同时可减少细胞凋亡。

GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 decreases apoptosis. GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) (pIC50: 6 in different cell-free assays).

GSK2795039 (25 μM; 24 hours) decreases the combinatory effect of FeSO4 and LPS-increased levels of apoptosis. It also reduced the presence of caspase-3-positive PC12 cells[2].

GSK2795039 (intraperitoneal injection; 100 mg/kg; 1 hour before) reduces activity in a murine model of acute pancreatitis. It also decreases the levels of serum amylase triggered by systemic injection of cerulein[1].

1415925-18-6

C23H26N6O2S

450.56

DMSO:31 mg/mL(68.8 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years